433 related articles for article (PubMed ID: 23474818)
1. ALS mutant FUS disrupts nuclear localization and sequesters wild-type FUS within cytoplasmic stress granules.
Vance C; Scotter EL; Nishimura AL; Troakes C; Mitchell JC; Kathe C; Urwin H; Manser C; Miller CC; Hortobágyi T; Dragunow M; Rogelj B; Shaw CE
Hum Mol Genet; 2013 Jul; 22(13):2676-88. PubMed ID: 23474818
[TBL] [Abstract][Full Text] [Related]
2. Directly converted patient-specific induced neurons mirror the neuropathology of FUS with disrupted nuclear localization in amyotrophic lateral sclerosis.
Lim SM; Choi WJ; Oh KW; Xue Y; Choi JY; Kim SH; Nahm M; Kim YE; Lee J; Noh MY; Lee S; Hwang S; Ki CS; Fu XD; Kim SH
Mol Neurodegener; 2016 Jan; 11():8. PubMed ID: 26795035
[TBL] [Abstract][Full Text] [Related]
3. Nuclear localization sequence of FUS and induction of stress granules by ALS mutants.
Gal J; Zhang J; Kwinter DM; Zhai J; Jia H; Jia J; Zhu H
Neurobiol Aging; 2011 Dec; 32(12):2323.e27-40. PubMed ID: 20674093
[TBL] [Abstract][Full Text] [Related]
4. ALS mutations of FUS suppress protein translation and disrupt the regulation of nonsense-mediated decay.
Kamelgarn M; Chen J; Kuang L; Jin H; Kasarskis EJ; Zhu H
Proc Natl Acad Sci U S A; 2018 Dec; 115(51):E11904-E11913. PubMed ID: 30455313
[TBL] [Abstract][Full Text] [Related]
5. RNA-binding ability of FUS regulates neurodegeneration, cytoplasmic mislocalization and incorporation into stress granules associated with FUS carrying ALS-linked mutations.
Daigle JG; Lanson NA; Smith RB; Casci I; Maltare A; Monaghan J; Nichols CD; Kryndushkin D; Shewmaker F; Pandey UB
Hum Mol Genet; 2013 Mar; 22(6):1193-205. PubMed ID: 23257289
[TBL] [Abstract][Full Text] [Related]
6. Aggregation of ALS-linked FUS mutant sequesters RNA binding proteins and impairs RNA granules formation.
Takanashi K; Yamaguchi A
Biochem Biophys Res Commun; 2014 Sep; 452(3):600-7. PubMed ID: 25173930
[TBL] [Abstract][Full Text] [Related]
7. ALS mutant FUS proteins are recruited into stress granules in induced pluripotent stem cell-derived motoneurons.
Lenzi J; De Santis R; de Turris V; Morlando M; Laneve P; Calvo A; Caliendo V; Chiò A; Rosa A; Bozzoni I
Dis Model Mech; 2015 Jul; 8(7):755-66. PubMed ID: 26035390
[TBL] [Abstract][Full Text] [Related]
8. Pur-alpha regulates cytoplasmic stress granule dynamics and ameliorates FUS toxicity.
Daigle JG; Krishnamurthy K; Ramesh N; Casci I; Monaghan J; McAvoy K; Godfrey EW; Daniel DC; Johnson EM; Monahan Z; Shewmaker F; Pasinelli P; Pandey UB
Acta Neuropathol; 2016 Apr; 131(4):605-20. PubMed ID: 26728149
[TBL] [Abstract][Full Text] [Related]
9. ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import.
Dormann D; Rodde R; Edbauer D; Bentmann E; Fischer I; Hruscha A; Than ME; Mackenzie IR; Capell A; Schmid B; Neumann M; Haass C
EMBO J; 2010 Aug; 29(16):2841-57. PubMed ID: 20606625
[TBL] [Abstract][Full Text] [Related]
10. Arginine methylation by PRMT1 regulates nuclear-cytoplasmic localization and toxicity of FUS/TLS harbouring ALS-linked mutations.
Tradewell ML; Yu Z; Tibshirani M; Boulanger MC; Durham HD; Richard S
Hum Mol Genet; 2012 Jan; 21(1):136-49. PubMed ID: 21965298
[TBL] [Abstract][Full Text] [Related]
11. Widespread FUS mislocalization is a molecular hallmark of amyotrophic lateral sclerosis.
Tyzack GE; Luisier R; Taha DM; Neeves J; Modic M; Mitchell JS; Meyer I; Greensmith L; Newcombe J; Ule J; Luscombe NM; Patani R
Brain; 2019 Sep; 142(9):2572-2580. PubMed ID: 31368485
[TBL] [Abstract][Full Text] [Related]
12. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6.
Vance C; Rogelj B; Hortobágyi T; De Vos KJ; Nishimura AL; Sreedharan J; Hu X; Smith B; Ruddy D; Wright P; Ganesalingam J; Williams KL; Tripathi V; Al-Saraj S; Al-Chalabi A; Leigh PN; Blair IP; Nicholson G; de Belleroche J; Gallo JM; Miller CC; Shaw CE
Science; 2009 Feb; 323(5918):1208-1211. PubMed ID: 19251628
[TBL] [Abstract][Full Text] [Related]
13. ALS-Related Mutant FUS Protein Is Mislocalized to Cytoplasm and Is Recruited into Stress Granules of Fibroblasts from Asymptomatic FUS P525L Mutation Carriers.
Lo Bello M; Di Fini F; Notaro A; Spataro R; Conforti FL; La Bella V
Neurodegener Dis; 2017; 17(6):292-303. PubMed ID: 29035885
[TBL] [Abstract][Full Text] [Related]
14. Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation.
Naumann M; Pal A; Goswami A; Lojewski X; Japtok J; Vehlow A; Naujock M; Günther R; Jin M; Stanslowsky N; Reinhardt P; Sterneckert J; Frickenhaus M; Pan-Montojo F; Storkebaum E; Poser I; Freischmidt A; Weishaupt JH; Holzmann K; Troost D; Ludolph AC; Boeckers TM; Liebau S; Petri S; Cordes N; Hyman AA; Wegner F; Grill SW; Weis J; Storch A; Hermann A
Nat Commun; 2018 Jan; 9(1):335. PubMed ID: 29362359
[TBL] [Abstract][Full Text] [Related]
15. Amyotrophic lateral sclerosis-linked FUS/TLS alters stress granule assembly and dynamics.
Baron DM; Kaushansky LJ; Ward CL; Sama RR; Chian RJ; Boggio KJ; Quaresma AJ; Nickerson JA; Bosco DA
Mol Neurodegener; 2013 Aug; 8():30. PubMed ID: 24090136
[TBL] [Abstract][Full Text] [Related]
16. Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis.
Verbeeck C; Deng Q; Dejesus-Hernandez M; Taylor G; Ceballos-Diaz C; Kocerha J; Golde T; Das P; Rademakers R; Dickson DW; Kukar T
Mol Neurodegener; 2012 Oct; 7():53. PubMed ID: 23046583
[TBL] [Abstract][Full Text] [Related]
17. Quantitative proteomics identifies proteins that resist translational repression and become dysregulated in ALS-FUS.
Baron DM; Matheny T; Lin YC; Leszyk JD; Kenna K; Gall KV; Santos DP; Tischbein M; Funes S; Hayward LJ; Kiskinis E; Landers JE; Parker R; Shaffer SA; Bosco DA
Hum Mol Genet; 2019 Jul; 28(13):2143-2160. PubMed ID: 30806671
[TBL] [Abstract][Full Text] [Related]
18. In vivo stress granule misprocessing evidenced in a FUS knock-in ALS mouse model.
Zhang X; Wang F; Hu Y; Chen R; Meng D; Guo L; Lv H; Guan J; Jia Y
Brain; 2020 May; 143(5):1350-1367. PubMed ID: 32358598
[TBL] [Abstract][Full Text] [Related]
19. ALS-associated mutations in FUS disrupt the axonal distribution and function of SMN.
Groen EJ; Fumoto K; Blokhuis AM; Engelen-Lee J; Zhou Y; van den Heuvel DM; Koppers M; van Diggelen F; van Heest J; Demmers JA; Kirby J; Shaw PJ; Aronica E; Spliet WG; Veldink JH; van den Berg LH; Pasterkamp RJ
Hum Mol Genet; 2013 Sep; 22(18):3690-704. PubMed ID: 23681068
[TBL] [Abstract][Full Text] [Related]
20. Fused in sarcoma (FUS) protein lacking nuclear localization signal (NLS) and major RNA binding motifs triggers proteinopathy and severe motor phenotype in transgenic mice.
Shelkovnikova TA; Peters OM; Deykin AV; Connor-Robson N; Robinson H; Ustyugov AA; Bachurin SO; Ermolkevich TG; Goldman IL; Sadchikova ER; Kovrazhkina EA; Skvortsova VI; Ling SC; Da Cruz S; Parone PA; Buchman VL; Ninkina NN
J Biol Chem; 2013 Aug; 288(35):25266-25274. PubMed ID: 23867462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
